VOYA Investment Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

VOYA Investment Management’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,169	Closed	-$79K	–	2605
2016 Q1	$79K	Hold	4,169	–	–	﹤0.01%	2438
2015 Q4	$111K	Hold	4,169	–	–	﹤0.01%	2463
2015 Q3	$190K	Sell	4,169 -1,433	-26%	-$54K	﹤0.01%	2292
2015 Q2	$180K	Hold	5,602	–	–	﹤0.01%	2514
2015 Q1	$178K	Hold	5,602	–	–	﹤0.01%	2459
2014 Q4	$212K	Hold	5,602	–	–	﹤0.01%	2451
2014 Q3	$148K	Hold	5,602	–	–	﹤0.01%	2563
2014 Q2	$166K	Hold	5,602	–	–	﹤0.01%	2608
2014 Q1	$207K	Hold	5,602	–	–	﹤0.01%	2487
2013 Q4	$232K	Hold	5,602	–	–	﹤0.01%	2443
2013 Q3	$297K	Hold	5,602	–	–	﹤0.01%	2299
2013 Q2	$299K	Buy	+5,602	New	+$280K	﹤0.01%	2250

Other funds holding NAVB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

VOYA Investment Management's NAVB Position: Q2 2016 in Review

VOYA Investment Management sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2016, closing a stake of 4,169 shares — an estimated $79K sold.

VOYA Investment Management first reported a position in NAVB in Q2 2013 and held it in 12 quarters. The position peaked at $299K in Q2 2013. 63 funds tracked by Wall St. Rank hold NAVB as of Q2 2016.

VOYA Investment Management reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
VOYA Investment Management sold 4,169 Navidea Biopharmaceuticals Inc. shares in Q2 2016, an estimated $79K.
VOYA Investment Management first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 12 quarters.
VOYA Investment Management's Navidea Biopharmaceuticals Inc. position peaked at $299K in Q2 2013.
63 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2016.

Based on VOYA Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.